Fluoropyrimidine
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
226 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Colorectal neoplasms | D015179 | — | — | 16 | 50 | 24 | 2 | 13 | 94 |
| Neoplasms | D009369 | — | C80 | 7 | 15 | 4 | 1 | 6 | 30 |
| Breast neoplasms | D001943 | EFO_0003869 | C50 | 3 | 7 | — | 1 | 2 | 11 |
| Liver neoplasms | D008113 | EFO_1001513 | C22.0 | 2 | 2 | — | 1 | 2 | 7 |
| Head and neck neoplasms | D006258 | — | — | 1 | 2 | — | 1 | — | 4 |
| Hepatocellular carcinoma | D006528 | — | C22.0 | 1 | 1 | — | 1 | — | 3 |
| Oncogenes | D009857 | — | — | — | — | — | 1 | — | 1 |
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Stomach neoplasms | D013274 | EFO_0003897 | C16 | 10 | 31 | 16 | — | 6 | 60 |
| Adenocarcinoma | D000230 | — | — | 1 | 11 | 8 | — | 1 | 21 |
| Rectal neoplasms | D012004 | — | — | 4 | 9 | 7 | — | 2 | 20 |
| Neoplasm metastasis | D009362 | EFO_0009708 | — | 2 | 12 | 5 | — | 1 | 18 |
| Esophageal neoplasms | D004938 | — | C15 | 3 | 11 | 1 | — | 3 | 17 |
| Colonic neoplasms | D003110 | — | C18 | 2 | 5 | 7 | — | 3 | 15 |
| Esophageal squamous cell carcinoma | D000077277 | — | — | 1 | 5 | 2 | — | 1 | 8 |
| Carcinoma | D002277 | — | C80.0 | 1 | 2 | 3 | — | 1 | 6 |
| Cholangiocarcinoma | D018281 | — | C22.1 | 1 | 1 | 1 | — | 3 | 6 |
| Squamous cell carcinoma | D002294 | — | — | 1 | 2 | 1 | — | 1 | 4 |
Show 5 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Pancreatic neoplasms | D010190 | EFO_0003860 | C25 | 5 | 5 | — | — | 3 | 11 |
| Gastrointestinal neoplasms | D005770 | — | C26.9 | 2 | 5 | — | — | 4 | 11 |
| Non-small-cell lung carcinoma | D002289 | — | — | 4 | 3 | — | — | — | 6 |
| Renal cell carcinoma | D002292 | EFO_0000376 | — | 3 | 2 | — | — | — | 4 |
| Triple negative breast neoplasms | D064726 | — | — | 2 | 2 | — | — | — | 4 |
| Squamous cell carcinoma of head and neck | D000077195 | — | — | 3 | 2 | — | — | — | 4 |
| Urologic neoplasms | D014571 | — | C64-C68 | 3 | 1 | — | — | — | 3 |
| Lung neoplasms | D008175 | — | C34.90 | — | 3 | — | — | — | 3 |
| Residual neoplasm | D018365 | — | — | — | 2 | — | — | — | 2 |
| Bile duct neoplasms | D001650 | — | — | — | 1 | — | — | 1 | 2 |
Show 25 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Castration-resistant prostatic neoplasms | D064129 | — | — | 2 | — | — | — | — | 2 |
| Gallbladder neoplasms | D005706 | EFO_0004606 | C23 | 1 | — | — | — | 1 | 2 |
| Appendiceal neoplasms | D001063 | EFO_0003880 | C18.1 | 1 | — | — | — | 1 | 2 |
| Ovarian neoplasms | D010051 | EFO_0003893 | C56 | 1 | — | — | — | — | 1 |
| Endometrial neoplasms | D016889 | EFO_0004230 | — | 1 | — | — | — | — | 1 |
| Thyroid neoplasms | D013964 | EFO_0003841 | — | 1 | — | — | — | — | 1 |
| Salivary gland neoplasms | D012468 | EFO_0003826 | D11 | 1 | — | — | — | — | 1 |
| Gastrointestinal stromal tumors | D046152 | EFO_0000505 | C49.A | 1 | — | — | — | — | 1 |
| Olfactory esthesioneuroblastoma | D018304 | EFO_1000407 | — | 1 | — | — | — | — | 1 |
| Mucinous adenocarcinoma | D002288 | — | — | 1 | — | — | — | — | 1 |
Show 3 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Cardiotoxicity | D066126 | EFO_1001482 | — | — | — | — | — | 3 | 3 |
| Drug-related side effects and adverse reactions | D064420 | — | T88.7 | — | — | — | — | 2 | 2 |
| Gastrointestinal microbiome | D000069196 | — | — | — | — | — | — | 1 | 1 |
| Hypertension | D006973 | EFO_0000537 | I10 | — | — | — | — | 1 | 1 |
| Cardiovascular diseases | D002318 | EFO_0000319 | I98 | — | — | — | — | 1 | 1 |
| Digestive system neoplasms | D004067 | — | — | — | — | — | — | 1 | 1 |
| Patient acceptance of health care | D010342 | — | — | — | — | — | — | 1 | 1 |
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | — |
| INN | — |
| Description | — |
| Classification | Unknown |
| Drug class | — |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | — |
Identifiers
| PDB | — |
| CAS-ID | — |
| RxCUI | — |
| ChEMBL ID | — |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | — |
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
31 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use